ASTH — APOLLO MED HLDGS INC

Ownership history in EntryPoint Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in APOLLO MED HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.26% (2023 Q4)
Avg. % of fund
0.14%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 13,477 +2,319 +20.8% 0.15% $382K $28.35
2025 Q2 ADDED 11,158 +10,770 +2775.8% 0.14% $278K $24.88
2024 Q2 REDUCED 388 -6,643 -94.5% 0.02% $16K $40.56
2023 Q4 INITIATED 7,031 — — 0.26% $269K —
% of Fund (quarterly)    ASTH price (monthly, adj. close)

Other funds also holding ASTH

As of 2025 Q4 — sorted by position size

325 CAPITAL LLC 3Y 15.99% 1492 Capital Management LLC 3Y 7Y 1.59% QSV Equity Investors LLC 1.09% SteelPeak Wealth, LLC 3Y 0.47% Insight Wealth Strategies, LLC 3Y 7Y 0.4% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.38% Shay Capital LLC 3Y 0.31% Capstone Capital Management Ltd 0.28% NorthCrest Asset Manangement, LLC 3Y 0.28% ROYCE & ASSOCIATES LP 3Y 7Y 0.09%
← Back to EntryPoint Capital, LLC Holdings